Chemistry Wealth Management’s Stellantis STLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,180
Closed -$525K 209
2025
Q4
$525K Sell
48,180
-14,147
-23% -$152K 0.1% 115
2025
Q3
$582K Sell
62,327
-4,995
-7% -$47.8K 0.11% 109
2025
Q2
$675K Buy
67,322
+5,083
+8% +$50.1K 0.14% 97
2025
Q1
$698K Buy
62,239
+15,846
+34% +$204K 0.16% 86
2024
Q4
$605K Sell
46,393
-10,318
-18% -$137K 0.14% 89
2024
Q3
$797K Buy
56,711
+7,407
+15% +$126K 0.19% 80
2024
Q2
$979K Buy
49,304
+2,802
+6% +$64.9K 0.25% 61
2024
Q1
$1.32M Sell
46,502
-530
-1% -$13.2K 0.35% 47
2023
Q4
$1.1M Buy
47,032
+29,345
+166% +$606K 0.33% 52
2023
Q3
$338K Buy
+17,687
New +$331K 0.11% 116

Other funds holding STLA

Chemistry Wealth Management's STLA Position: Q1 2026 in Review

Chemistry Wealth Management sold out of Stellantis (STLA) in Q1 2026, closing a stake of 48,180 shares — an estimated $525K sold.

Chemistry Wealth Management first reported a position in STLA in Q3 2023 and held it in 10 quarters. The position peaked at $1.32M in Q1 2024. 401 funds tracked by Wall St. Rank hold STLA as of Q1 2026.

  • Chemistry Wealth Management reported no remaining Stellantis position as of Q1 2026 after selling out during the quarter.
  • Chemistry Wealth Management sold 48,180 Stellantis shares in Q1 2026, an estimated $525K.
  • Chemistry Wealth Management first reported a position in Stellantis in Q3 2023 and held it in 10 quarters.
  • Chemistry Wealth Management's Stellantis position peaked at $1.32M in Q1 2024.
  • 401 funds tracked by Wall St. Rank held Stellantis as of Q1 2026.

Based on Chemistry Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.